According to research report the ECMO Machine Market was valued at $531 million in 2021 and is expected to reach $673 million by 2026, growing at a compound annual growth rate of 4.9% during that period. ECMO machines provide prolonged cardiac and respiratory support to critically ill patients.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=255167654
The growth of this market is driven primarily by the expanding geriatric population and increasing prevalence of chronic respiratory diseases and cardiovascular diseases globally. For instance, chronic obstructive pulmonary disease (COPD) is the third leading cause of death worldwide. ECMO machines are increasingly being used in lung transplantation procedures as well, especially for patients with severe acute respiratory distress syndrome (ARDS).
Technological advancements have significantly contributed to the increased adoption of ECMO machines, enabling faster and more precise diagnosis and treatment compared to older equipment. However, challenges such as high costs associated with ECMO therapies, limited healthcare budgets in developing countries, and declining insurance reimbursements remain impediments to widespread adoption.
Despite these challenges, the rising utilization of ECMO machines has led to improved survival rates for critical cardiac and respiratory cases, presenting promising opportunities for manufacturers and medical providers. Development of portable and user-friendly ECMO devices, along with training programs to enhance the pool of qualified ECMO specialists, are avenues for market expansion.
The respiratory care segment holds the largest market share, driven by the growing prevalence of pulmonary diseases, while arterio-venous ECMO modalities dominate due to their dynamic range and diagnostic value. Usage of ECMO machines for adults accounts for the greatest market share, particularly benefiting older patients with heart and lung failure.
Geographically, the Asia-Pacific region is expected to witness the fastest growth rate in the ECMO machine market, attributed to factors such as the expanding elderly population, rising disposable incomes, and supportive government policies.
Leading players in the global ECMO machine market, including Getinge Group, Medtronic, Fresenius Medical Care, Microport, and Terumo Cardiovascular Systems Corporation, are focusing on new product development and partnerships to enhance competitiveness. Regulatory approvals for new ECMO devices in key markets such as the U.S. and China underscore ongoing innovations in the field.
Request Free Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=255167654
In conclusion, the combination of increasing chronic cardiovascular and respiratory illnesses globally, coupled with technological advancements, is driving growth in the ECMO machine market. While challenges persist, companies are investing in research, development, and geographic expansion to capitalize on this market’s strong growth potential in the coming years.
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
sales@marketsandmarkets.com
